Functional characteristics of synovial fluid and blood mononuclear cells in rheumatoid arthritis and traumatic synovitis. 1982

J Petersen, and V Andersen, and G Bendixen, and K Bendtzen, and J Halkjaer-Kristensen, and T Ingemann-Hansen, and A Wiik

The activity of blood mononuclear cells (BMC) and synovial fluid mononuclear cells (SMC) from patients with rheumatoid arthritis (RA) and traumatic synovitis (TS) was assessed by means of [14C]thymidine incorporation and production of leukocyte migration inhibitory factor (LIF). When compared with normal controls, spontaneous LIF production by BMC was found in 5 of 9 TS patients, whereas spontaneous LIF production by rheumatoid arthritis BMC and by SMC from both patient groups was infrequently seen. ConA-induced LIF production by BMC and SMC from both patient groups did not differ significantly from that of normal controls. Thymidine incorporation by unstimulated SMC and BMC was low in both patient groups. After stimulation with polyclonal activators, SMC showed significantly reduced proliferation in comparison with BMC, but the responses to microbial antigens were equal to or higher than those of BMC. The proliferative responses of stimulated SMC from TS patients were higher than the responses displayed by stimulated SMC from RA patients.

UI MeSH Term Description Entries
D007961 Leukocyte Migration-Inhibitory Factors Protein factor(s) released by sensitized lymphocytes (and possibly other cells) that inhibit the movement of LEUKOCYTES, especially polymorphonuclear cells, away from their site of release. Assays for these factors are used as tests for cellular immunity. Two of the common assays are the LEUKOCYTE MIGRATION CAPILLARY TUBE TECHNIQUE (LMCT) and the LEUKOCYTE MIGRATION AGAROSE TEST (LMAT). Migration-Inhibition Factors, Leukocyte,Leukocyte Migration-Inhibition Factors,Migration-Inhibitory Factors, Leukocyte,Factors, Leukocyte Migration-Inhibition,Factors, Leukocyte Migration-Inhibitory,Leukocyte Migration Inhibition Factors,Leukocyte Migration Inhibitory Factors,Migration Inhibition Factors, Leukocyte,Migration Inhibitory Factors, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

J Petersen, and V Andersen, and G Bendixen, and K Bendtzen, and J Halkjaer-Kristensen, and T Ingemann-Hansen, and A Wiik
August 2010, Clinica chimica acta; international journal of clinical chemistry,
J Petersen, and V Andersen, and G Bendixen, and K Bendtzen, and J Halkjaer-Kristensen, and T Ingemann-Hansen, and A Wiik
April 2000, The Journal of rheumatology,
J Petersen, and V Andersen, and G Bendixen, and K Bendtzen, and J Halkjaer-Kristensen, and T Ingemann-Hansen, and A Wiik
January 1976, Arthritis and rheumatism,
J Petersen, and V Andersen, and G Bendixen, and K Bendtzen, and J Halkjaer-Kristensen, and T Ingemann-Hansen, and A Wiik
June 1987, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology,
J Petersen, and V Andersen, and G Bendixen, and K Bendtzen, and J Halkjaer-Kristensen, and T Ingemann-Hansen, and A Wiik
February 1995, Immunology letters,
J Petersen, and V Andersen, and G Bendixen, and K Bendtzen, and J Halkjaer-Kristensen, and T Ingemann-Hansen, and A Wiik
December 1993, Acta medica Okayama,
J Petersen, and V Andersen, and G Bendixen, and K Bendtzen, and J Halkjaer-Kristensen, and T Ingemann-Hansen, and A Wiik
January 1978, Scandinavian journal of immunology,
J Petersen, and V Andersen, and G Bendixen, and K Bendtzen, and J Halkjaer-Kristensen, and T Ingemann-Hansen, and A Wiik
March 2011, Human immunology,
J Petersen, and V Andersen, and G Bendixen, and K Bendtzen, and J Halkjaer-Kristensen, and T Ingemann-Hansen, and A Wiik
January 1995, Rheumatology international,
J Petersen, and V Andersen, and G Bendixen, and K Bendtzen, and J Halkjaer-Kristensen, and T Ingemann-Hansen, and A Wiik
November 1992, The Tohoku journal of experimental medicine,
Copied contents to your clipboard!